Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in Chest Retrieve available abstracts of 122 articles: HTML format

Single Articles

October 2025
1. MARMOR M, Brunton AE, Fraulino D, Ruoss SJ, et al
   Research Letter: The Association Between Incident Nontuberculous Mycobacteria Isolation and Antibiotic Exposure in Patients with Bronchiectasis.
   Chest. 2025 Oct 9:S0012-3692(25)05493-5. doi: 10.1016/j.chest.2025.
   PubMed    
   
   
   
2. LIU C, Xiong H, Han X, Lv Y, et al
   Association of Physical Frailty With Incidence and Life Expectancy of COPD: A Population-Based Cohort Study.
   Chest. 2025;168:890-900.
   PubMed     Abstract available
   
   
   
3. BOERS E, Allen A, Barrett M, Benjafield AV, et al
   Forecasting the Global Economic and Health Burden of COPD From 2025 Through 2050.
   Chest. 2025;168:880-889.
   PubMed     Abstract available
   
   
   September 2025
4. TEELUCKSINGH S, Davis A, Nelson-Piercy C
   Asthma and Pregnancy: A Narrative Review.
   Chest. 2025 Sep 25:S0012-3692(25)05382-6. doi: 10.1016/j.chest.2025.
   PubMed     Abstract available
   
   
   
5. OBERLE AJ, Abbas F, Adrish M, Agache I, et al
   Biologic Management in Severe Asthma for Adults: An American College of Chest Physician Clinical Practice Guideline.
   Chest. 2025 Sep 24:S0012-3692(25)05380-2. doi: 10.1016/j.chest.2025.
   PubMed     Abstract available
   
   
   
6. KL S, Ab C, LA V, St Y, et al
   Pediatric bronchiectasis action management plan to improve clinical outcomes: An RCT.
   Chest. 2025 Sep 8:S0012-3692(25)05164-5. doi: 10.1016/j.chest.2025.
   PubMed     Abstract available
   
   
   
7. NOBLE JH, Warhurst S, Cullen R, Sayers R, et al
   THE DOSE-RESPONSE OF INHALED CORTICOSTEROIDS IN COMBINATION ICS/LABA MAINTENANCE THERAPY FOR ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
   Chest. 2025 Sep 3:S0012-3692(25)05145-1. doi: 10.1016/j.chest.2025.
   PubMed     Abstract available
   
   
   
8. KAHRIMAN B, Satici C
   Beyond Emphysema: Unraveling Reversibility and Inflammatory Profiles in Mild to Moderate COPD.
   Chest. 2025;168:e86-e87.
   PubMed    
   
   
   
9. LI Q, Qin KL, Liu Y, Zhang LY, et al
   Recognition Delay and Heterogeneity in Inflammatory Bowel Diseases-Related Bronchiectasis: From Real-World Data to Precision Management.
   Chest. 2025;168:e81-e82.
   PubMed    
   
   
   
10. LI X, Feng S, Yang Y, Liang Z, et al
    Association Between Airway Mucus Plugs and Risk of Moderate-to-Severe Exacerbations in Patients With COPD: Results From a Chinese Prospective Cohort Study.
    Chest. 2025;168:627-638.
    PubMed     Abstract available
    
    
    
11. MUNN JS, Austin PC, Atzema CL, Butler SJ, et al
    Investigating the Long-Term Effects of COVID-19 Infection on Health Care Utilization in Individuals With COPD.
    Chest. 2025;168:613-626.
    PubMed     Abstract available
    
    
    
12. DEHONDT V, Vauterin D, Derom E, Lahousse L, et al
    Association of Timely Spirometry With Lower All-Cause Mortality: A Nationwide Obstructive Cohort Study.
    Chest. 2025;168:602-612.
    PubMed     Abstract available
    
    
    August 2025
13. SHEIKH S, Eisner M, Kelin W, Kilbarger J, et al
    Intermittent Asthma and Risk of Severe Exacerbation in Children.
    Chest. 2025 Aug 27:S0012-3692(25)05124-4. doi: 10.1016/j.chest.2025.07.4089.
    PubMed     Abstract available
    
    
    
14. DAI C, Huang YH
    Bronchiectasis in Patients With Inflammatory Bowel Diseases: Uncertain Association and Future Direction.
    Chest. 2025;168:e45-e46.
    PubMed    
    
    
    
15. COUILLARD S, Ramakrishnan S
    In the Land of Asthma, 4 Risk Factors to Rule Them All.
    Chest. 2025;168:277-279.
    PubMed    
    
    
    
16. MAHLER DA, Halpin DMG
    Selecting an Inhaled Delivery System in COPD.
    Chest. 2025;168:402-409.
    PubMed     Abstract available
    
    
    
17. SCHAEFFER MR, Vanden Bossche L, Beckers K, Verbeke K, et al
    Inhaled Menthol for Dyspnea Relief During Cycle Exercise in COPD: A Randomized Trial.
    Chest. 2025;168:390-401.
    PubMed     Abstract available
    
    
    
18. EKSTROM M, Li PZ, Lewthwaite H, Bourbeau J, et al
    Phenotyping Exertional Breathlessness Using Cardiopulmonary Cycle Exercise Testing in People With Chronic Airflow Limitation.
    Chest. 2025;168:379-389.
    PubMed     Abstract available
    
    
    July 2025
19. BACKMAN H, Myrberg T, Hedman L, Stridsman C, et al
    Importance of Preserved Ratio Impaired Spirometry as a Risk Factor for Development of COPD, Also in Those Who Do Not Smoke.
    Chest. 2025;168:83-94.
    PubMed     Abstract available
    
    
    
20. KALRA S, Hobbs B, Hunninghake GM, Menon AA, et al
    The Association of Interstitial Lung Abnormalities and Preserved Ratio Impaired Spirometry With Mortality.
    Chest. 2025;168:136-145.
    PubMed     Abstract available
    
    
    
21. BHATT SP, Rabe KF, Hanania NA, Vogelmeier CF, et al
    Effect of Dupilumab on Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS.
    Chest. 2025;168:56-66.
    PubMed     Abstract available
    
    
    June 2025
22. KIM H, Choi SH, Ryerson CJ, George PM, et al
    Combined Interstitial Features and Emphysema in National Lung Screening Trial Participants: Prognostic Implications.
    Chest. 2025 Jun 18:S0012-3692(25)00715-9. doi: 10.1016/j.chest.2025.
    PubMed    
    
    
    
23. ALTREE TJ, Pinczel AJ, Toson B, Loffler KA, et al
    The Effects of Low-Dose Morphine on Sleep and Breathlessness in COPD: A Randomized Trial.
    Chest. 2025;167:1578-1590.
    PubMed     Abstract available
    
    
    May 2025
24. SERAJEDDINI H, Thakar A, Kjarsgaard M, Huang C, et al
    Sputum Cellularity and MRI Ventilation Defects in Severe Asthma.
    Chest. 2025 May 20:S0012-3692(25)00648-8. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
25. YADAV CP, Chakraborty A, Price DB, Mien Lim LH, et al
    Prediction pathway for severe asthma exacerbations: a Bayesian Network analysis.
    Chest. 2025 May 19:S0012-3692(25)00647-6. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
26. YILMAZ I, Turk M
    Differences in Expert Opinion on Selection of Initial Biologics and Biologic Switching in Severe Asthma.
    Chest. 2025;167:e167.
    PubMed    
    
    
    
27. CELLI BR, Anzueto A, Singh D, Hanania NA, et al
    The Emerging Role of Alarmin-Targeting Biologics in the Treatment of Patients With COPD.
    Chest. 2025;167:1346-1355.
    PubMed     Abstract available
    
    
    
28. FENG Z, Li G, He Q, Sun N, et al
    Associations of Socioeconomic Status and Phenotypic Frailty With Incident COPD: Findings From UK Biobank Participants.
    Chest. 2025;167:1321-1332.
    PubMed     Abstract available
    
    
    April 2025
29. PELAIA G, Jackson DJ, Nair P, Emmanuel B, et al
    XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma.
    Chest. 2025 Apr 19:S0012-3692(25)00441-6. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
30. AGARWAL R, Muthu V, Sehgal IS
    Evaluation for Allergic Bronchopulmonary Aspergillosis in Patients With Bronchiectasis.
    Chest. 2025;167:e143.
    PubMed    
    
    
    
31. HATANO H, Akamatsu T, Shirai T
    Considerations on Potential Overestimation of Asthma Prevalence.
    Chest. 2025;167:e141.
    PubMed    
    
    
    
32. KHOO YK, Kor AC, Lee CH
    Advancing Lung Ultrasound: Development and Application of the Lung Curtain Swing vs Time Graph in Assessing Asthma Exacerbation.
    Chest. 2025;167:e127-e131.
    PubMed    
    
    
    
33. AARON SD
    Early Diagnosis and Treatment of COPD and Asthma.
    Chest. 2025;167:943-944.
    PubMed    
    
    
    
34. CARTER C, Shah A
    The Fungal Frontier: Understanding the Impact of Aspergillus in Bronchiectasis.
    Chest. 2025;167:914-916.
    PubMed    
    
    
    
35. MERRELL E, Georas SN
    Is Tissue the Issue When It Comes to Severe Asthma?
    Chest. 2025;167:911-913.
    PubMed    
    
    
    
36. HERNANDEZ P, Bosse Y, Bush P, Chapman KR, et al
    Alpha-1-Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Meta-Analysis and Clinical Practice Guideline.
    Chest. 2025;167:1044-1063.
    PubMed     Abstract available
    
    
    
37. ZHOU P, Yu W, Zhang W, Ma J, et al
    COPD-Associated Expiratory Central Airway Collapse: Current Concepts and New Perspectives.
    Chest. 2025;167:1024-1043.
    PubMed     Abstract available
    
    
    
38. COX NS, McDonald C, Burge AT, Hill CJ, et al
    Comparison of Clinically Meaningful Improvements After Center-Based and Home-Based Telerehabilitation in People With COPD.
    Chest. 2025;167:1003-1011.
    PubMed     Abstract available
    
    
    
39. BROCK JM, Dittrich SA, Eichhorn F, Schlamp K, et al
    Lessons Learned: Risk Factors and Clinical Impact of Severe Pneumothorax After Endoscopic Lung Volume Reduction With Endobronchial Valves.
    Chest. 2025;167:1012-1023.
    PubMed     Abstract available
    
    
    March 2025
40. FREUND O, Bar-Shai A, Alkhazov A, Stav D, et al
    Bronchiectasis in patients with inflammatory bowel diseases - prevalence, predictors, and clinical characteristics.
    Chest. 2025 Mar 28:S0012-3692(25)00405-2. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
41. HERMANN EA, Yang JX, Angelini E, Balte P, et al
    CT Emphysema Subtypes and Cardiac Hemodynamics Estimated on Magnetic Resonance Imaging: The MESA COPD Study.
    Chest. 2025 Mar 27:S0012-3692(25)00399-X. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
42. CHOI H, Kwak IY, Oh CR, Goo JM, et al
    Prevalence of Airflow Limitation and Emphysema in Lung Cancer Screening Populations: A Systematic Review and Meta-analysis.
    Chest. 2025 Mar 5:S0012-3692(25)00270-3. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
43. HENDERSON CJ, Lesnick BL
    Obstructive Lung Disease in Osteogenesis Imperfecta: A Potential Model for Interstitial Lung Disease, COPD, and Asthma.
    Chest. 2025;167:645-646.
    PubMed    
    
    
    
44. EKSTROM M, Lewthwaite H, Li PZ, Bourbeau J, et al
    Identifying Abnormal Exertional Breathlessness in COPD: Comparing Modified Medical Research Council and COPD Assessment Test With Cardiopulmonary Exercise Testing.
    Chest. 2025;167:697-711.
    PubMed     Abstract available
    
    
    
45. SUISSA S, Dell'Aniello S, Ernst P
    Single-Inhaler Triple vs Long-Acting Beta(2)-Agonist-Inhaled Corticosteroid Therapy for COPD: Comparative Safety in Real-World Clinical Practice.
    Chest. 2025;167:712-723.
    PubMed     Abstract available
    
    
    
46. PANKOVITCH S, Frohlich M, AlOthman B, Marciniuk J, et al
    Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program: A Real-World Observational Study.
    Chest. 2025;167:736-745.
    PubMed     Abstract available
    
    
    
47. ANDERSEN JD, Lyster ML, Holst MK, Henriksen DP, et al
    Risk of Pulmonary Diseases in Osteogenesis Imperfecta in Denmark: A Register-Based Cohort Study.
    Chest. 2025;167:806-817.
    PubMed     Abstract available
    
    
    February 2025
48. MOZAFFARIPOUR A, Tcherner S, McIntosh MJ, Kooner HK, et al
    Does the Reversal and Normalization of Airway and Pulmonary Vascular Remodeling Accompany Asthma Remission?
    Chest. 2025 Feb 14:S0012-3692(25)00160-6. doi: 10.1016/j.chest.2025.
    PubMed    
    
    
    
49. AMBROSINO P, Vitacca M, Marcuccio G, Spanevello A, et al
    A Comparison of GOLD and STAR Severity Stages in Individuals With COPD Undergoing Pulmonary Rehabilitation.
    Chest. 2025;167:387-401.
    PubMed     Abstract available
    
    
    
50. COLLINS SE, Kirby M, Smith BM, Tan W, et al
    Relationship of Pulmonary Vascular Structure and Function With Exercise Capacity in Health and COPD.
    Chest. 2025;167:402-413.
    PubMed     Abstract available
    
    
    
51. CHOI JY, Lee CH, Joo H, Sim YS, et al
    Implications of Global Lung Function Initiative Spirometry Reference Equations in Northeast Asian Patients With COPD.
    Chest. 2025;167:414-424.
    PubMed     Abstract available
    
    
    
52. CESTELLI L, Johannessen A, Gulsvik A, Stavem K, et al
    Risk Factors, Morbidity, and Mortality in Association With Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern: Clinical Relevance of Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern.
    Chest. 2025;167:548-560.
    PubMed     Abstract available
    
    
    
53. SCIURBA FC, Christenson SA, Rheault T, Bengtsson T, et al
    Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD.
    Chest. 2025;167:425-435.
    PubMed     Abstract available
    
    
    
54. COSTA FILHO FF, Buckley JD, Furlan A, Campbell S, et al
    Inpatient Complication Rates of Bronchoscopic Lung Volume Reduction in the United States.
    Chest. 2025;167:436-443.
    PubMed     Abstract available
    
    
    January 2025
55. MCCRAVY MS, Ingram JL, Que LG
    Weighing the Options: New Insights and Ongoing Challenges in Asthma With Obesity.
    Chest. 2025;167:1-2.
    PubMed    
    
    
    
56. MARSAA K, Guldin MB, Marques A, Pinnock H, et al
    Understanding Nonpharmacologic Palliative Care for People With Serious COPD: The Individual and Organizational Perspective.
    Chest. 2025;167:112-120.
    PubMed     Abstract available
    
    
    
57. HARVEY-DUNSTAN TC, Baldwin MM, Tal-Singer R, Allinder M, et al
    The Responsiveness of Exercise Tests in COPD: A Randomized Controlled Trial.
    Chest. 2025;167:98-111.
    PubMed     Abstract available
    
    
    
58. ECKHARDT CM, Wu H, Jackson G, Sobel MH, et al
    Extracellular Vesicle-Encapsulated microRNAs and Respiratory Health Among American Indian Participants in the Strong Heart Study.
    Chest. 2025;167:87-97.
    PubMed     Abstract available
    
    
    
59. KIM DH, Jeon ET, Lee HJ, Park H, et al
    Longitudinal Changes in Maximal Forced Inspiratory Flow and Clinical Outcomes in Patients With COPD.
    Chest. 2025;167:76-86.
    PubMed     Abstract available
    
    
    December 2024
60. COSIO BG, Iglesias A, Shafiek H, Mosteiro M, et al
    The role of bronchial biopsy in the prediction of response to biological therapy in severe uncontrolled asthma: a prospective study.
    Chest. 2024 Dec 30:S0012-3692(24)05733-7. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
61. CHAN R, Gochicoa-Rangel L, Cottini M, Comberiati P, et al
    Ascertainment of small airway dysfunction using oscillometry to better define asthma control and future risk: are we ready to implement it in clinical practice?
    Chest. 2024 Dec 27:S0012-3692(24)05728-3. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
62. JESENAK M, Bobcakova DA, Djukanovic R, Gaga M, et al
    Promoting Prevention and Targeting Remission of Asthma A EUFOREA Consensus Statement on Raising the Bar in Asthma Care.
    Chest. 2024 Dec 11:S0012-3692(24)05617-4. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
63. BUSSE WW, Pavord ID, Wechsler ME, Davila IJ, et al
    Stability of Fractional Exhaled Nitric Oxide and its Relationship with Exacerbation in Patients Aged 6 Years or Older with Uncontrolled, Moderate-to-Severe Asthma.
    Chest. 2024 Dec 2:S0012-3692(24)05601-0. doi: 10.1016/j.chest.2024.
    PubMed    
    
    
    
64. JIN Z
    Further Discussion Regarding the Increased Risk of Pertussis in Populations With Asthma or COPD.
    Chest. 2024;166:e201.
    PubMed    
    
    
    
65. BIERBRIER J, Gerstein E, Whitmore GA, Vandemheen KL, et al
    Impact of Dyspnea on Adults With Respiratory Symptoms Without a Defined Diagnosis.
    Chest. 2024;166:1296-1308.
    PubMed     Abstract available
    
    
    
66. OLENGA VUVU LOFUTA P, Klass M, Pauwen N, Kipula AM, et al
    Occupational Exposure to Charcoal Smoke and Dust, a Major Risk Factor for COPD: A Multiregional Cross-Sectional Study in the Democratic Republic of Congo.
    Chest. 2024;166:1334-1346.
    PubMed     Abstract available
    
    
    
67. AKULA M, Nguyen M, Abraham J, Arora VM, et al
    Determining If COPD Self-Management Televisit-Based Interventions Are Evaluated Among and Equitably Effective Across Diverse Patient Populations to Reduce Acute Care Use: A Scoping Review.
    Chest. 2024;166:1371-1393.
    PubMed     Abstract available
    
    
    November 2024
68. MURRAY JK, McNally E, Kent BD
    Clinical accuracy and risk of harm in asthma related content on TikTok.
    Chest. 2024 Nov 9:S0012-3692(24)05466-7. doi: 10.1016/j.chest.2024.
    PubMed    
    
    
    
69. KHALAF Z, Saglani S, Bloom CI
    Implementation and effectiveness of guideline-recommended clinical activities for children with asthma: population-based cohort.
    Chest. 2024 Nov 6:S0012-3692(24)05442-4. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
70. CHOTIRMALL SH, Chang AB, Chalmers JD
    Infection vs Inflammation: The Bronchiectasis "Tug Of War".
    Chest. 2024;166:928-930.
    PubMed    
    
    
    
71. ZHUO B, Ran S, Qian AM, Zhang J, et al
    Air Pollution Metabolomic Signatures and Chronic Respiratory Diseases Risk: A Longitudinal Study.
    Chest. 2024;166:975-986.
    PubMed     Abstract available
    
    
    
72. MATHIOUDAKIS AG, Bate S, Sivapalan P, Jensen JS, et al
    Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD: A Post Hoc Analysis From the FLAME Trial.
    Chest. 2024;166:987-997.
    PubMed     Abstract available
    
    
    
73. NIU Y, Niu H, Meng X, Zhu Y, et al
    Associations Between Air Pollution and the Onset of Acute Exacerbations of COPD: A Time-Stratified Case-Crossover Study in China.
    Chest. 2024;166:998-1009.
    PubMed     Abstract available
    
    
    
74. BREMS JH, Vick J, Ashana D, Beach MC, et al
    "Against Medical Advice" Discharges After Respiratory-Related Hospitalizations: Strategies for Respectful Care.
    Chest. 2024;166:1155-1161.
    PubMed     Abstract available
    
    
    
75. METTLER SK, Nath HP, Grumley S, Orejas JL, et al
    Silent Airway Mucus Plugs in COPD and Clinical Implications.
    Chest. 2024;166:1010-1019.
    PubMed     Abstract available
    
    
    October 2024
76. CHOI H, Hughes C, Eke Z, Shuttleworth M, et al
    Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.
    Chest. 2024 Oct 25:S0012-3692(24)05418-7. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
77. POLLOCK J, Goeminne PC, Aliberti S, Polverino E, et al
    Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Chest. 2024 Oct 24:S0012-3692(24)05400-X. doi: 10.1016/j.chest.2024.06.3843.
    PubMed     Abstract available
    
    
    
78. YANG H, Yang Y, Wang F, Miao C, et al
    Clinical and Prognostic Differences in Mild to Moderate COPD With and Without Emphysema.
    Chest. 2024 Oct 23:S0012-3692(24)05397-2. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
79. SHARMA V, Ricketts HC, McCombie L, Brosnahan N, et al
    A one-year weight management programme for difficult-to-treat asthma with obesity: a randomised controlled study.
    Chest. 2024 Oct 18:S0012-3692(24)05320-0. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
80. CHALMERS JD, Burgel PR, Daley CL, DE-Soyza A, et al
    TEMPORARY REMOVAL: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BRENSOCATIB IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS - THE ASPEN TRIAL.
    Chest. 2024;166.
    PubMed     Abstract available
    
    
    
81. JIN Z
    Does Rheumatoid Arthritis Increase the Risk of COPD?
    Chest. 2024;166:e126-e127.
    PubMed    
    
    
    
82. CARR TF
    The Lifelong Burden of Severe Childhood Asthma.
    Chest. 2024;166:653-654.
    PubMed    
    
    
    
83. ROZENBERG D, Reid WD, Camp P, Campos JL, et al
    Translating the Interplay of Cognition and Physical Performance in COPD and Interstitial Lung Disease: Meeting Report and Literature Review.
    Chest. 2024;166:721-732.
    PubMed     Abstract available
    
    
    
84. QUINTERO SANTOFIMIO V, Knox-Brown B, Potts J, Bartlett-Pestell S, et al
    Small Airways Obstruction and Mortality: Findings From the UK Biobank.
    Chest. 2024;166:712-720.
    PubMed     Abstract available
    
    
    September 2024
85. COUILLARD S, Jackson DJ, Pavord ID, Wechsler ME, et al
    How I do it. Choosing the right biologic for the right patient with severe asthma.
    Chest. 2024 Sep 6:S0012-3692(24)05139-0. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    August 2024
86. SUEN AO, Bischoff K, Iyer AS, Radhakrishnan K, et al
    Differences in Healthcare and Palliative Care Utilization at the End of Life: a Comparison Study Between Lung Cancer, COPD, and IPF.
    Chest. 2024 Aug 24:S0012-3692(24)05049-9. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
87. TELLO K, Yogeswaran A, Majeed RW, Kiely DG, et al
    Phosphodiesterase-5 Inhibitor Treatment is Associated with Improved Survival in Pulmonary Hypertension Associated with COPD in the PVRI GoDeep Meta-Registry.
    Chest. 2024 Aug 23:S0012-3692(24)05046-3. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
88. COSTANTINI JG, Lo JC, Ko J, Chandra M, et al
    Ethnic Variation in Asthma Prevalence across Childhood in the Asian American and Pacific Islander Population.
    Chest. 2024 Aug 22:S0012-3692(24)04999-7. doi: 10.1016/j.chest.2024.
    PubMed    
    
    
    
89. WANG JM, Araki T, Cottin V, Han MK, et al
    Quantitative imaging methods in combined pulmonary fibrosis and emphysema.
    Chest. 2024 Aug 16:S0012-3692(24)04921-3. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
90. RHOADS SL, Mohan A
    A Novel Examination of Azithromycin as a Low-Cost Intervention to Achieve Remission in Asthma.
    Chest. 2024;166:241-242.
    PubMed    
    
    
    
91. BREMS JH, Balasubramanian A, Raju S, Putcha N, et al
    Changes in Spirometry Interpretative Strategies: Implications for Classifying COPD and Predicting Exacerbations.
    Chest. 2024;166:294-303.
    PubMed     Abstract available
    
    
    July 2024
92. YANG HM, Ryu MH, Carey VJ, Young K, et al
    COPD Subtypes Are Differentially Associated with Cardiovascular Events and COPD Exacerbations.
    Chest. 2024 Jul 31:S0012-3692(24)04878-5. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
93. WALLSTROM O, Stridsman C, Lindberg A, Nyberg F, et al
    Exacerbation history and risk of myocardial infarction and pulmonary embolism in chronic obstructive pulmonary disease.
    Chest. 2024 Jul 31:S0012-3692(24)04880-3. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
94. PATTI MA, Henderson NB, Phipatanakul W, Jackson-Browne M, et al
    Recommendations for Clinicians to Combat Environmental Disparities in Pediatric Asthma: A Review.
    Chest. 2024 Jul 24:S0012-3692(24)04845-1. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
95. VAN GANSE E, Louis R
    International Severe Asthma Registry: Closer to the Full Picture of Asthma Care and Outcomes?
    Chest. 2024;166:3-4.
    PubMed    
    
    
    
96. BOURBEAU J, Sin DD
    Global Initiative for Chronic Obstructive Lung Disease and Canadian Thoracic Society COPD Guidelines: Two Sides of the Same Coin or Different Coins?
    Chest. 2024;166:24-27.
    PubMed    
    
    
    
97. SUISSA S
    COUNTERPOINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? No.
    Chest. 2024;166:17-20.
    PubMed    
    
    
    
98. ADRISH M, Hanania NA
    POINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? Yes.
    Chest. 2024;166:12-17.
    PubMed    
    
    
    
99. EKSTROM M, Li PZ, Lewthwaite H, Bourbeau J, et al
    Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation.
    Chest. 2024;166:81-94.
    PubMed     Abstract available
    
    
    June 2024
100. SAVRAN O, Bonnelykke K, Ulrik CS
     Characteristics of adults with severe asthma in childhood - A 60-year Follow-up Study.
     Chest. 2024 Jun 28:S0012-3692(24)00806-7. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
101. EWEN R, Pink I, Sutharsan S, Aries SP, et al
     Primary Ciliary Dyskinesia in Adult Bronchiectasis - Data from the German Bronchiectasis Registry PROGNOSIS.
     Chest. 2024 Jun 14:S0012-3692(24)00703-7. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
102. SATICI C, Bek EO
     The Role of Electronic Nose Analysis of Exhaled Air in Detection of Lung Cancer Among Patients With COPD.
     Chest. 2024;165:e201.
     PubMed    
     
     
     
103. ROSSIDES M
     Rheumatoid Arthritis and COPD: Thinking Beyond Smoking.
     Chest. 2024;165:1278-1279.
     PubMed    
     
     
     
104. MCDERMOTT GC, Sparks JA
     Rheumatoid Arthritis and Bronchiectasis Risk: Additional Evidence Linking Autoimmunity and Airways Disease.
     Chest. 2024;165:1276-1277.
     PubMed    
     
     
     
105. FARMER MJS, Callahan CD, Hughes AM, Riska KL, et al
     Applying Noninvasive Ventilation in Treatment of Acute Exacerbation of COPD Using Evidence-Based Interprofessional Clinical Practice.
     Chest. 2024;165:1469-1480.
     PubMed     Abstract available
     
     
     
106. CHUNG C, Kim H, Han K, Jung J, et al
     Does Rheumatoid Arthritis Increase the Risk of COPD?: A Nationwide Retrospective Cohort Study.
     Chest. 2024;165:1362-1371.
     PubMed     Abstract available
     
     
     
107. KAMINSKA M, Adam V, Orr JE
     Home Noninvasive Ventilation in COPD.
     Chest. 2024;165:1372-1379.
     PubMed     Abstract available
     
     
     May 2024
108. TAN DJ, van Geffen WH, Walters EH
     Impact of Triple Therapy vs Dual Bronchodilator Therapy on Mortality Rates in COPD.
     Chest. 2024;165:e158-e159.
     PubMed    
     
     
     
109. WU WW, Wang G
     How Much Do We Know About Clinical Response and Remission to Add-On Biologics in Severe Asthma in a Real-World Setting.
     Chest. 2024;165:e157-e158.
     PubMed    
     
     
     
110. JOHNSON KM, Duan KI
     The Growing Burden of COPD in the United States.
     Chest. 2024;165:1027-1028.
     PubMed    
     
     
     
111. MANNINO DM, Roberts MH, Mapel DW, Zhang Q, et al
     National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029.
     Chest. 2024;165:1093-1106.
     PubMed     Abstract available
     
     
     April 2024
112. LEE H, Moon JY, Min KH
     Real-World Clinical Studies to Understand the Current Status and Future Improvements of Pulmonary Rehabilitation in Chronic Lung Diseases.
     Chest. 2024;165:e125.
     PubMed    
     
     
     
113. ASH SY
     Quantitative Imaging and Bronchial Thermoplasty: Technically Impressive But Clinically Uncertain.
     Chest. 2024;165:755-756.
     PubMed    
     
     
     
114. SAMANT M, Krings JG, Lew D, Goss CW, et al
     Use of Quantitative CT Imaging to Identify Bronchial Thermoplasty Responders.
     Chest. 2024;165:775-784.
     PubMed     Abstract available
     
     
     
115. RYU MH, Murphy S, Hinkley M, Carlsten C, et al
     COPD Exposed to Air Pollution: A Path to Understand and Protect a Susceptible Population.
     Chest. 2024;165:836-846.
     PubMed     Abstract available
     
     
     
116. ARON J, Baldomero AK, Rau A, Fiecas MB, et al
     Individual Risk Factors of PM(2.5) Associated With Wintertime Mortality in Urban Patients With COPD.
     Chest. 2024;165:825-835.
     PubMed     Abstract available
     
     
     March 2024
117. GUPTA S, Couillard S, Digby G, Tse SM, et al
     Climate Change and Inhaler Selection in Patients With Respiratory Disease.
     Chest. 2024;165:503-506.
     PubMed    
     
     
     
118. SAHAY S
     Rebuttal From Dr Sahay.
     Chest. 2024;165:498-499.
     PubMed    
     
     
     
119. BINEY IN, Ari A, Barjaktarevic IZ, Carlin B, et al
     Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium.
     Chest. 2024;165:653-668.
     PubMed     Abstract available
     
     
     
120. HE D, Yan M, Zhou Y, Ge H, et al
     Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study.
     Chest. 2024;165:573-582.
     PubMed     Abstract available
     
     
     February 2024
121. THOMAS D, McDonald VM, Stevens S, Baraket M, et al
     Azithromycin induced asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomised, double-blind, placebo-controlled trial.
     Chest. 2024 Feb 29:S0012-3692(24)00284-8. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     
     
122. LEE TY, Price D, Yadav CP, Roy R, et al
     International variation in severe exacerbation rates in patients with severe asthma.
     Chest. 2024 Feb 21:S0012-3692(24)00264-2. doi: 10.1016/j.chest.2024.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.